Medico Intercontinental Fair Value
Medico Intercontinental (MIL) average fair value is ₹77.74 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹22.87 (+239.92%), fair value range ₹49.0–₹122.75. See MIL book value comparison to compare market price against book value per share.
Fair Value Analysis Export
MIL Fair Value vs Current Price — Valuation Summary
MIL average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. Examine Medico Intercontinental quarterly financials for recent quarterly revenue, profit and EPS trends.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
MIL Fair Value Analysis — Data Sources & Coverage
Medico Intercontinental financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. For live price and a broader fundamental view, visit MIL share price.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
MIL vs Commercial Services Sector Peers — P/E, P/B & Market Cap
Medico Intercontinental P/E ratio, P/B ratio and market capitalisation vs Commercial Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Quasar | QUASAR | - | 0.14 | ₹14 |
| Maximus International | MAXIMUS | 14.93 | 1.72 | ₹136 |
| Viksit Engineering | VIKSHEN | - | - | - |
| Sarthak Global | SARTHAKGL | 22.19 | 5.34 | ₹11 |
| Real Growth Corporation | RGCORP | - | - | - |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.